Nolato ABFRA:NBF +2.27%75 OCF Yield % is 8.83 as of Jul. 02, 2026, which is 42% above its 10-year median of 6.20. GuruFocus rates FRA:NBF with a GF Score™ of 75/100 and a GF Value™ of €4.74 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Nolato AB ranks better than 82.57% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Nolato AB's OCF Yield % or its related term are showing as below:
FRA:NBF'
s OCF Yield % Range Over the Past 10 Years
Min: 2.22 Med: 6.2 Max: 11.19
Current: 8.83
During the past 13 years, the highest OCF Yield % of Nolato AB was 11.19%. The lowest was 2.22%. And the median was 6.20%.
FRA:NBF's OCF Yield % is ranked better than 82.57% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: 1.71
vs FRA:NBF: 8.83
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Nolato AB OCF Yield % Related Terms
Nolato AB OCF Yield % Historical Data
* Premium members only.
The historical data trend for Nolato AB's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Nolato AB's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nolato AB OCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nolato AB's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Nolato AB's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nolato AB (FRA:NBF) has a OCF Yield % of 8.83 as of Jul. 02, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Nolato AB and its competitors. This is 42% above median its historical median of 6.20. Over the past decade, Nolato AB's OCF Yield % has ranged from 2.22 to 11.19. According to the industry distribution chart, Nolato AB ranks #149 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 17.4%.
Is Nolato AB's OCF Yield % too high?
Nolato AB's current OCF Yield % of 8.83 is 42% above median its 10-year median of 6.20. Over the past 10 years, this metric has ranged from a low of 2.22 to a high of 11.19. The Medical Devices & Instruments industry median OCF Yield % is 1.71. Nolato AB's value of 8.83 is 416.4% above this industry median. Based on the distribution chart, Nolato AB ranks #149 out of 855 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Nolato AB has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nolato AB's OCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Nolato AB ranks #149 out of 855 companies for OCF Yield %. This places Nolato AB in the top 17% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 1.71. Nolato AB's value of 8.83 is 416.4% above this benchmark. Historically, Nolato AB's own OCF Yield % has ranged from 2.22 to 11.19 over the past decade. While the company's 10-year median is 6.20 vs. the industry median of 1.71, Nolato AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.71, based on 855 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nolato AB's current OCF Yield % of 8.83 is 416.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Nolato AB and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nolato AB's current OCF Yield % is 8.83, which is 42% above median its own 10-year median of 6.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nolato AB stock overvalued right now?
Based on GuruFocus' analysis, Nolato AB (FRA:NBF) is currently considered Modestly Undervalued. The stock's GF Value™ is €4.74, compared to a current price of €4.29 — trading 9.6% below its estimated fair value. The current OCF Yield % is 8.83, which is 42% above median its 10-year median of 6.20 and 416.4% above the Medical Devices & Instruments industry median of 1.71. Nolato AB's overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Nolato AB (FRA:NBF), the current OCF Yield % is 8.83 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nolato AB (FRA:NBF) Overvalued in 2026?
Based on GuruFocus' analysis, Nolato AB stock appears to be undervalued.
The current stock price of €4.29 is trading 9.6% below its estimated GF Value™ of €4.74.
GuruFocus considers Nolato AB to be Modestly Undervalued.
Key valuation signals for FRA:NBF:
OCF Yield %: 8.83 (42% above median its 10-year median of 6.20)
GF Value™: €4.74 vs. price of €4.29 (9.6% below fair value)
Industry Position: 416.4% above the Medical Devices & Instruments median (#149 of 855)
No single metric tells the full story. See the FRA:NBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nolato AB is a Swedish company that develops and manufactures plastic, silicone, and thermoplastic elastomer products. The firm's operations are organized into two segments: Medical Solutions and Engineered Solutions. The company generates the majority of its revenue from the Medical Solutions segment, which is engaged in the development and manufacture of complex product systems and components for medical devices, the pharmaceutical industry, and diagnostics. The Engineered Solutions design, development, industrialization, and manufacture of subsystems and ready-packaged products for a range of industries, including offerings within EMC and thermal solutions. Geographically, the firm generates key revenue from the Rest of Europe and the United States.
75GF Score
Get the complete analysis for FRA:NBF
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:NBF has been successfully added to your 
